Dr. Figueroa received her MD from Universidad del Salvador, School of Medicine in Buenos Aires, Argentina in 1997. After completing her internal medicine residency, she went on to train as a hematologist at the Institute for Hematological Research “Mariano Castex” at the National Academy of Medicine in Buenos Aires, where she later joined the Malignant Hematology Department. In 2004 Dr. Figueroa joined Dr. Ari Melnick’s laboratory in New York. During her postdoctoral training with Dr. Melnick, Dr. Figueroa’s research focused on the characterization of epigenetic deregulation in myeloid malignancies, particularly Acute Myeloid Leukemia and Myelodysplastic Syndromes. In 2011 Dr. Figueroa started her independent career as an Assistant Professor at the University of Michigan Medical School, where she continued her work in the field of epigenetic regulation of normal and malignant hematopoiesis. In September 2016 she was recruited as Associate Professor to the University of Miami Miller School of Medicine. She also serves as the Co-Leader Cancer Epigenetics Research Program and Assistant Director for Translational Research for the Sylvester Comprehensive Cancer Center. Throughout her career, Dr. Figueroa has been the recipient of scholar awards from the SASS Foundation for Cancer Research, the American Society of Hematology, The Leukemia and Lymphoma Society, and the Doris Duke Charitable Foundation.

Michaëla Fontenay, MD, PhD, full professor of Hematology at Université Paris Cité. Affiliations: Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Cité - Assistance-Publique-Hôpitaux de Paris. Centre, Hôpital Cochin - Head manager of the laboratory of Hematology and of the Unit of clinical haemostasis of Cochin AP-HP.Centre University Hospital Teaching: Hematology, Faculty of Medicine, Université Paris Cité - Co-director of PhD school Hematology Oncogenesis, Biotechnology, Université Paris Cité, Research: Director of INSERM team Normal and pathological hematopoiesis, Institut Cochin Expertise: myelodysplastic syndrome pathophysiology, normal and pathological erythropoiesis, stem cell biology, RNA biology Society membership: ASH, EHA, SFH, MDS-RIGHT consortium, EHA-SWG MDS, EHA-SWG Red cell, IWG-PM/MDS Foundation Reviewing activities: N Engl J Med, Nature Med, Nature Immunol, Blood, Leukemia, Haematologica Invited professor University of Florence, Italy, 2019 Invited conferences: American Society of Hematology, European Hematology Association 2009-2019, European School of Hematology, MSKCC, US Red blood cell club, Gordon conference, Keystone symposium, MDS Foundation, Société Française d’Hématologie. Publications: 175 articles in peer reviewed journals (Cell, Nature, N Engl J Med, Sci Transl Med, Blood, Leukemia, Haematologica…) Keywords: hematopoiesis, erythropoiesis, myeloid malignancies, leukemia, microenvironment, innate immunity, COVID-19

Lucie is a resident in clinical hematology at the Saint-Louis Hospital. She is especially interested in genetic predispositions to hematological malignancies and is currently doing her medical thesis on germline CHEK2 pathogenic variant in patients diagnosed with a myeloid malignancy.